Abstract
Depressive disorders are a frequent psychiatric comorbidity in patients with neurologic disease with prevalence rates ranging between 30% and 50%. Yet, despite their relative high prevalence, they remain underrecognized and undertreated. Depressive disorders can have a negative impact on the course and response to treatment of several neurologic disorders, including stroke, migraine, epilepsy, Parkinson's disease, and Alzheimer's dementia. This chapter reviews some of the evidence and tries to make the case of why neurologists should care to recognize early the presence of a comorbid depressive disorder and facilitate its treatment.
| Original language | English (US) |
|---|---|
| Title of host publication | Depression in Neurologic Disorders: Diagnosis and Management |
| Publisher | Wiley-Blackwell |
| Pages | 1-9 |
| Number of pages | 9 |
| ISBN (Print) | 9781444330588 |
| DOIs | |
| State | Published - Jul 4 2012 |
| Externally published | Yes |
Fingerprint
Keywords
- Hippocampal atrophy
- Interictal dysphoric disorder
- Major depressive disorders
- Orbitofrontal atrophy
- Poststroke depression
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
Depression in Neurologic Disorders : Why Should Neurologists Care? / Kanner, Andres M.
Depression in Neurologic Disorders: Diagnosis and Management. Wiley-Blackwell, 2012. p. 1-9.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Depression in Neurologic Disorders
T2 - Why Should Neurologists Care?
AU - Kanner, Andres M
PY - 2012/7/4
Y1 - 2012/7/4
N2 - Depressive disorders are a frequent psychiatric comorbidity in patients with neurologic disease with prevalence rates ranging between 30% and 50%. Yet, despite their relative high prevalence, they remain underrecognized and undertreated. Depressive disorders can have a negative impact on the course and response to treatment of several neurologic disorders, including stroke, migraine, epilepsy, Parkinson's disease, and Alzheimer's dementia. This chapter reviews some of the evidence and tries to make the case of why neurologists should care to recognize early the presence of a comorbid depressive disorder and facilitate its treatment.
AB - Depressive disorders are a frequent psychiatric comorbidity in patients with neurologic disease with prevalence rates ranging between 30% and 50%. Yet, despite their relative high prevalence, they remain underrecognized and undertreated. Depressive disorders can have a negative impact on the course and response to treatment of several neurologic disorders, including stroke, migraine, epilepsy, Parkinson's disease, and Alzheimer's dementia. This chapter reviews some of the evidence and tries to make the case of why neurologists should care to recognize early the presence of a comorbid depressive disorder and facilitate its treatment.
KW - Hippocampal atrophy
KW - Interictal dysphoric disorder
KW - Major depressive disorders
KW - Orbitofrontal atrophy
KW - Poststroke depression
UR - http://www.scopus.com/inward/record.url?scp=84886338938&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84886338938&partnerID=8YFLogxK
U2 - 10.1002/9781118348093.ch1
DO - 10.1002/9781118348093.ch1
M3 - Chapter
AN - SCOPUS:84886338938
SN - 9781444330588
SP - 1
EP - 9
BT - Depression in Neurologic Disorders: Diagnosis and Management
PB - Wiley-Blackwell
ER -